key: cord-0707639-f1ysa032
authors: Soerjomataram, Isabelle; Bardot, Aude; Aitken, Joanne; Piñeros, Marion; Znaor, Ariana; Steliarova‐Foucher, Eva; Kohler, Betsy; Bettio, Manola; Matsuda, Tomohiro; de Camargo Cancela, Marianna; Mery, Les; Bray, Freddie
title: Impact of the COVID‐19 pandemic on population‐based cancer registry
date: 2021-09-18
journal: Int J Cancer
DOI: 10.1002/ijc.33792
sha: 4c0166f5053d8f2cc9197cae68cac62f486a069a
doc_id: 707639
cord_uid: f1ysa032

The COVID‐19 pandemic has caused disruptions to national health systems and impacted health outcomes worldwide. However, the extent to which surveillance systems, such as population‐based cancer registration, have been affected was not reported. Here we sought to evaluate the effect of the pandemic on registry operations across different areas and development levels worldwide. We investigated the impact of COVID‐19 on three main areas of cancer registry operations: staffing, financing and data collection. An online survey was administered to 750 member registries of the International Association for Cancer Registries. Among 212 responding registries from 90 countries, 65.6% reported a disruption in operations, ranging between 45% in south‐eastern Asia and 87% in the Latin America and Caribbean. Active data collection was disrupted more than case notifications or hybrid methods. In countries categorized with low Human Development Index (HDI), a greater number of registries reported a negative impact (81.3%) than in very high HDI countries (57.8%). This contrast was highest in term of impact on financing: 9/16 (56%) registries in low HDI countries reported a current or an expected decline in funding, compared to 7/108 (7%) in very high HDI countries. With many cancer registries worldwide reporting disruption to their operations during the early COVID‐19 pandemic, urgent actions are needed to ensure their continuity. Governmental commitment to support future registry operations as an asset to disease control, alongside a move toward electronic reporting systems will help to ensure the sustainability of cancer surveillance worldwide.

greater number of registries reported a negative impact (81.3%) than in very high HDI countries (57.8%). These results emphasize the need for actionable, strategic plans to ensure the continuity of registry operations globally.

Several studies have reported substantially higher morbidity and mortality from COVID-19 among patients with cancer. 1, 2 Additionally, the COVID-19 pandemic has had far-reaching consequences on the delivery of activities across the cancer continuum, including national screening programs and cancer care. 3 As an indirect consequence of national responses to the early phase of the COVID-19 pandemic, there were delays in diagnoses, referrals and testing of symptomatic cases; delays or changes in cancer management; and changes in the provision of palliative care. 4, 5 In the Netherlands, a decrease in recorded cancer cases during the 2.5 month lockdown was attributed to patient's concerns about possible exposure to SARS-CoV-2 in a health-care setting, and decreased interaction with clinicians linked to social distancing and lockdown policies. 6 In Italy, pathology departments, an important data source for cancer registries, have reported 39% fewer cancer diagnoses in this period compared to average numbers in previous years. 7 The temporary suspension of cancer screening programs has also been reported as a further cause of reduced cancer diagnoses during the lockdown. 4, 8 Population-based cancer registries (PBCR) produce incidence and survival at the population level to monitor and evaluate of cancer control interventions, and thus the provision of an evidence base for the development of national cancer control plans. During the COVID-19 pandemic, registries provided valuable insights into health system disruptions to cancer diagnosis and cancer care pathways, and the estimation of the direct or indirect impact of the pandemic on cancer outcomes. 4, 5, 9 As with many institutions during the pandemic, the operations of PBCR have been affected. In our study we sought to assess the impact of the first wave of the pandemic on cancer surveillance systems globally.

A questionnaire comprising 33 questions (64% closed-ended-ordinal or nominal, with some dependent on preceding answers) was formulated to assess disruptions to cancer registry operations early in the COVID-19 pandemic (provided in Appendix S1). The questionnaire was structured into three major areas of potential disruption:

(a) staffing, (b) financing and (c) data collection. 10 Two aspects of data collection were investigated, namely "passive" collection, where data retrieval relies on health workers to complete notification (e-)forms that are then forwarded to the registries, as well as "active" collection where registry staff visit the various data sources to identify and abstract the relevant data.

Additionally, an open-ended question to assess contingency strategies that have been implemented at the registry to minimize the pandemic's impact on registry operation was also asked. The questionnaire was developed in an iterative process and 

Of the 230 registries that responded, 18 had a high degree of missing data and were excluded. The remaining 212 valid responses from 90 countries were included in the analyses. There were 203 general PBCRs (collecting cancer data for all age groups and cancer sites) and 9 pediatric or specialized PBCRs (collecting data on a defined section of population). In total, 65.6% (n = 139) of respondents reported a change (responded "Yes" to "Have your registry operations (including staffing and funding) been affected by COVID-19?") in the cancer registry operations (Table 1) ; this proportion ranged between 45% in South-East Asia to 87% in the Caribbean and Latin America ( Figure 1 ). When categorized by HDI, the changes in registry operations ranged between 57.8% (n = 63/109) in countries with very high HDI to 81.3% (n = 13/16) in countries with low HDI. Of the three registry operation themes potentially impacted, namely staffing, financing and data collection, the latter was the activity most frequently affected, with 54% (n = 115) of registries reporting some disruption.

Additionally, 26% (n = 56) of registries were subject to changes in staffing and 18% (n = 37) suffered from financial cuts ( Table 1 ).

The impact on staff was mainly related to inadequate working conditions (57%, n = 32), reassignments to other departments (52%, n = 29) or staff having to care for family members (48%, n = 27).

There was no clear pattern of staff disruption by HDI category (Table S1 ), yet more frequent disruption in registry staffing was seen in the Middle East and North Africa (56%, n = 10/18), and Caribbean and Latin America (44%, n = 20/46) compared to South-East Asia or sub-Saharan Africa (9%, respectively n = 2/22 and n = 5/54) or Oceania (10%, n = 1/10) (Table S2) .

The reported or expected reduction in financing was greatest among registries that were dependent on governmental funding (70% of financially affected registries, n = 26). Reductions in financing were also reported in other settings, including registries based in hospitals (32%, n = 12), and those based in, or funded through, academic institutions (30%, n = 11), local nonprofit organizations (27%, n = 10) or research grants (24%, n = 9). A clear pattern was seen by HDI level (Table S3) ; the proportion of registries reporting financial reduction was largest in low and medium HDI countries (56%, n = 9/16 and 32%, n = 6/19, respectively) and smallest in high HDI countries (23%, n = 15/66 in high HDI, and 7%, n = 7/108 in very high). According to world region (Table S4) Finally, a complete disruption of passive data collection varied from 2% to 17% of impacted registries across data sources (Table S5) , while complete disruption to active data collection was even more common, ranging between 4% and 44% across sources. A marked contrast in the impact on data collection was seen by HDI group (Table S6) , with collection impacted in 75%, 63%, 60% and 46% of registries in low HDI through to very high HDI countries respectively; those particularly affected were located in Latin America and the Caribbean and (85%, n = 39/45) and sub-Saharan Africa (74%, n = 17/23) (Table S7) . Registries with disrupted data collection reported a reduction in registrations ranging from 8% to 85% across sources (Table 1) where applicable and feasible.

The development of innovative IT solutions and the ability to import data from sources electronically is key to future sustainability of PBCRs. About 45% of included PBCRs reported that contingency measures have been taken to mitigate impact of the pandemic, including enhanced IT capacity and security. Rapid technological uptake and implementation during this early period of the pandemic have been raised by many registries as a silver lining of the pandemic. Disruption to data access was clearly related to HDI status, with registries in low and medium HDI countries most affected, highlighting the urgent need to address the technology gap to remedy health inequalities in the very regions where cancer data is lacking. 14, 15 In reality, many registries struggle with their current financial situation, that particularly in registries in sub-Saharan Africa (48%). Studies have shown that resource requirements for cancer registration is relatively modest, ranging from US $3.77 to US $15.67 per cancer case in low to middle income countries. 16 The need for increased financial support as well as technical assistance to bring innovation to cancer registration in these settings is even greater in the present context of the pandemic.

In addition to operational factors, various external factors have caused additional challenges for cancer registries to deliver on their mandate in providing a comprehensive and timely situation analysis of the cancer burden. In the national registry of the Netherlands, a 27% drop in the number cancer cases was reported due to a decrease in data flow from pathology departments and referrals for cancer 

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Mortality due to cancer treatment delay: systematic review and meta-analysis

Safeguarding cancer care in a post-COVID-19 world

The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in The Netherlands

Impact of COVID-19 on cancer diagnosis and management in Slovenia: preliminary results

Fewer cancer diagnoses during the COVID-19 epidemic in The Netherlands

Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology

Consequences of COVID-19 for cancer care: a CRUK perspective

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Planning and Developing Population-Based Cancer Registration in Low-and Middle-Income Settings. Lyon: IARC

beyond Today: Inequalities in Human Development in the 21st Century

How will country-based mitigation measures influence the course of the COVID-19 epidemic?

An Asian perspective of the management of COVID-19: the Asian National Cancer Centers Alliance led Regional Comparison

Population-based cancer registration in sub-Saharan Africa: its role in research and cancer control

Cancer registration for cancer control in Latin America: a status and progress report

Resource requirements for cancer registration in areas with limited resources: analysis of cost data from four low-and middle-income countries

Decline in New Cancer Diagnoses in April Due to Corona Crisis in Belgium. Brussels: Belgian Cancer Registry

Covid-19: urgent cancer referrals fall by 60%, showing "brutal" impact of pandemic

Effect of the COVID-19 pandemic on surgical breast cancer care in The Netherlands: a multicenter retrospective cohort study

Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care

Modeling reporting delays and reporting corrections in cancer registry data

The authors declare no conflicts of interest.

The data that support the findings of our study are available upon reasonable request from the corresponding author.

Ethical approval for our study was not sought for as the unit of analy-